Partial reduction of sympathetic noradrenaline synthesis enhanced insulin secretion and cell-cycle-associated activity of pancreatic β cells in mice
American Journal of Physiology-Cell Physiology · 2026
DOI: 10.1152/ajpcell.00957.2025 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, 2026. Verfasst von Ryohei Ogawa und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Science and Technology, Institute of Science Tokyo, Yokohama, Japan. Hauptthemen laut MEDLINE: Insulin-Secreting Cells, Norepinephrine, Insulin Secretion, Insulin. Gefördert von: MEXT | JST | Support for Pioneering Research Initiated by the Next Generation (SPRING), Japan Agency for Medical Research and Development (AMED).
Abstract (Originalsprache)
Type 2 diabetes is caused by dysfunction of pancreatic β cells. Sympathetic neurons innervate pancreatic β cells and noradrenaline inhibits insulin secretion and proliferation of pancreatic β cells in vitro. Previously, we have generated a genetically engineered mice exhibiting inducible and sympathetic neuron-selective loss of the tyrosine hydroxylase gene ( Th-cKO mice), resulting in approximately 70% decline of pancreatic noradrenaline levels. In this study, we investigated the effects of sustained and downregulated sympathetic noradrenergic signaling on the pancreatic β cells using Th-cKO mice. Intraperitoneal glucose tolerance test revealed higher glucose tolerance in Th-cKO mice than the control mice without any difference in insulin tolerance test. Th-cKO mice also exhibited higher circulating insulin levels under glucose challenge. We also found that proliferative activity of pancreatic β cells increased in Th-cKO mice. These results indicate that partial and sustained suppression of sympathetic noradrenaline signaling could enhance insulin secretion and proliferative activity of pancreatic β cells. Additionally, we found that Th-cKO mice showed partial alleviation of streptozotocin-induced hyperglycemia accompanied by increased β cell proliferative response. Our data suggest that sympathetic noradrenaline synthesis can be a potential therapeutic target for diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Science and Technology, Institute of Science Tokyo, Yokohama, Japan.
ORCID-Profile: Ryohei Ogawa, Hiroshi Ichinose
Förderung
- MEXT | JST | Support for Pioneering Research Initiated by the Next Generation (SPRING)
- Japan Agency for Medical Research and Development (AMED)
Zitieren
APA
Ogawa, R., Suzuki, M., Hara, S., Sakano, D., Kume, S., & Ichinose, H. (2026). Partial reduction of sympathetic noradrenaline synthesis enhanced insulin secretion and cell-cycle-associated activity of pancreatic β cells in mice. American Journal of Physiology-Cell Physiology. https://doi.org/10.1152/ajpcell.00957.2025
Vancouver
Ogawa R, Suzuki M, Hara S, Sakano D, Kume S, Ichinose H. Partial reduction of sympathetic noradrenaline synthesis enhanced insulin secretion and cell-cycle-associated activity of pancreatic β cells in mice. American Journal of Physiology-Cell Physiology. 2026. doi:10.1152/ajpcell.00957.2025
BibTeX
@article{Ogawa2026,
author = {Ogawa, Ryohei and Suzuki, Minori and Hara, Satoshi and Sakano, Daisuke and Kume, Shoen and Ichinose, Hiroshi},
title = {Partial reduction of sympathetic noradrenaline synthesis enhanced insulin secretion and cell-cycle-associated activity of pancreatic β cells in mice},
journal = {American Journal of Physiology-Cell Physiology},
year = {2026},
doi = {10.1152/ajpcell.00957.2025}
}
EUVIMED